The frequency of naïve (A, CD27+CD45RA+), central memory (B, CD27+CD45RA-), and effector memory (C, CD27-CD45RA-) CD4+ T cells in the peripheral blood was longitudinally determined by flow cytometry. Blue arrows in A show the timing of 4 anti-CD4 antibody administrations to the anti-CD4 antibody treatment group. Anti-CD4 antibody treated animals (n = 6) are shown in red; control animals (n = 4) are shown in black. Data are expressed as mean ± SEM. Statistical analyses were performed using unpaired two-sided Mann–Whitney U-tests. Statistical significance was considered when P (TIF)</p
<p>A, Representative gating strategy of peripheral blood mononuclear cells with live gate, CD4 and C...
(A-B) 106 CD45.1 OT1 T cells were transferred i.v. into CD45.2+ mice, treated with anti-CD8α or –β t...
(A) Plasma viral load (HIV-RNA copies/ml) was quantified in longitudinal plasma samples using a qRT-...
The frequency of naïve (A, CD27+CD45RA+), central memory (B, CD27+CD45RA-), and effector memory (C, ...
(A) Experimental design of anti-CD4 antibody treatment in humanized mice. (B) The frequency of human...
The frequency of activated (CD38+HLA-DR+) CD4+ (A) and CD8+ (B) T cells in the peripheral blood was ...
(A) Experimental design of HIV infection and anti-CD4 antibody treatment in humanized mice. The freq...
(A) Experimental design of HIV infection and anti-CD4 antibody treatment in humanized mice. (B) The ...
The absolute number of human CD3+ T cells (A), CD4+ T cells (B) and CD8+ T cells (C) in the tissues ...
The frequency of human CD3+ T cells (A), CD4+ T cells (B) and CD8+ T cells (C) in tissues of anti-CD...
The frequency of activated (CD38+HLA-DR+) CD4+ (A) and CD8+ (B) T cells was determined by flow cytom...
<p>A. On day 45 after the second immunization, PBMC, splenocytes and pancreas cells were immunostain...
<p>(A, B) Flow cytometry contour plots of splenocytes obtained at day 14 after final immunization (A...
<p>A. On day 7 after the second immunization, the PBMC and splenocytes were prepared and immunostain...
<p>One week after the last immunization, spleen cells from IT/Saline, IT/rSm22.6, IT/rSm29, rSm22.6 ...
<p>A, Representative gating strategy of peripheral blood mononuclear cells with live gate, CD4 and C...
(A-B) 106 CD45.1 OT1 T cells were transferred i.v. into CD45.2+ mice, treated with anti-CD8α or –β t...
(A) Plasma viral load (HIV-RNA copies/ml) was quantified in longitudinal plasma samples using a qRT-...
The frequency of naïve (A, CD27+CD45RA+), central memory (B, CD27+CD45RA-), and effector memory (C, ...
(A) Experimental design of anti-CD4 antibody treatment in humanized mice. (B) The frequency of human...
The frequency of activated (CD38+HLA-DR+) CD4+ (A) and CD8+ (B) T cells in the peripheral blood was ...
(A) Experimental design of HIV infection and anti-CD4 antibody treatment in humanized mice. The freq...
(A) Experimental design of HIV infection and anti-CD4 antibody treatment in humanized mice. (B) The ...
The absolute number of human CD3+ T cells (A), CD4+ T cells (B) and CD8+ T cells (C) in the tissues ...
The frequency of human CD3+ T cells (A), CD4+ T cells (B) and CD8+ T cells (C) in tissues of anti-CD...
The frequency of activated (CD38+HLA-DR+) CD4+ (A) and CD8+ (B) T cells was determined by flow cytom...
<p>A. On day 45 after the second immunization, PBMC, splenocytes and pancreas cells were immunostain...
<p>(A, B) Flow cytometry contour plots of splenocytes obtained at day 14 after final immunization (A...
<p>A. On day 7 after the second immunization, the PBMC and splenocytes were prepared and immunostain...
<p>One week after the last immunization, spleen cells from IT/Saline, IT/rSm22.6, IT/rSm29, rSm22.6 ...
<p>A, Representative gating strategy of peripheral blood mononuclear cells with live gate, CD4 and C...
(A-B) 106 CD45.1 OT1 T cells were transferred i.v. into CD45.2+ mice, treated with anti-CD8α or –β t...
(A) Plasma viral load (HIV-RNA copies/ml) was quantified in longitudinal plasma samples using a qRT-...